0000874015-18-000079.txt : 20180703
0000874015-18-000079.hdr.sgml : 20180703
20180703151020
ACCESSION NUMBER: 0000874015-18-000079
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180701
FILED AS OF DATE: 20180703
DATE AS OF CHANGE: 20180703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WENDER JOSEPH H
CENTRAL INDEX KEY: 0001073384
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19125
FILM NUMBER: 18936637
MAIL ADDRESS:
STREET 1: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000874015
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330336973
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
BUSINESS PHONE: 7609319200
MAIL ADDRESS:
STREET 1: 2855 GAZELLE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92010
FORMER COMPANY:
FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2018-07-01
0000874015
IONIS PHARMACEUTICALS INC
IONS
0001073384
WENDER JOSEPH H
C/O IONIS PHARMACEUTICALS, INC.
2855 GAZELLE COURT
CARLSBAD
CA
92010
1
0
0
0
Common Stock
2018-07-01
2018-07-01
4
M
0
2000
0
A
38249
D
Common Stock
2018-07-03
2018-07-03
4
M
0
667
0
A
38916
D
Common Stock
38916
I
By Joseph H Wender Trust
Restricted Stock Units
2018-07-01
2018-07-01
4
M
0
2000
0
D
Common Stock
2000
1999
D
Restricted Stock Units
2018-07-03
2018-07-03
4
M
0
667
0
D
Common Stock
667
2000
D
Restricted Stock Units
2018-07-02
2018-07-02
4
A
0
3555
0
A
Common Stock
3555
3555
D
Director Stock Option (right to buy)
42.88
2018-07-02
2018-07-02
4
A
0
16000
0
A
2019-07-02
2028-07-01
Common Stock
16000
16000
D
Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit awards.
Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company.
Grant of July 2, 2018 to reporting person of Restricted Stock Unit Award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. Restricted Stock Units vest in four equal annual installments, the first installment vesting on July 2, 2019. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on July 2, 2022. The RSU is vested as to 0 shares on July 2, 2018.
Grant of July 2, 2018 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in four equal annual installments, the first installment vesting on July 2, 2019. The option shall be fully vested and exercisable on July 2, 2022. The option is exercisable to 0 shares on July 2, 2018.
/s/Patrick R. O'Neil, attorney-in-fact
2018-07-03